November 26, 2008
Bayer HealthCare LLC has agreed to pay the United States $97.5 million to resolve allegations that the company paid kickbacks to diabetic suppliers and caused those suppliers to submit false claims to Medicare.
The settlement resolves allegations that Bayer engaged in a cash-for-patient scheme through which the company paid 11 diabetic suppliers to convert their patients to Bayer’s products from supplies manufactured by its competitors.